Advocating for a world where intellectual
property law serves the public interest.

NY Times Op-ed: Scare Tactics Over Foreign Drugs

An Op-Ed appeared in today’s New York Times criticizing the United States Food and Drug Administration’s conflation of counterfeit drugs with legitimate medications imported by Americans seeking lower prices for their own use. Click here for the full op-ed on nytimes.com Author Gabriel Levitt

Ireland, Plain Packaging, and the Olive Revolution

A world leader in public health, Australia introduced plain packaging of tobacco products. Julia Gillard – the Prime Minister of Australia at the time responsible for plain packaging – has observed: “Since 1 December 2012, cigarettes packets in Australia do not sparkle with gold or silver and do not have any other way to catch […]

The Transatlantic Trade and Investment Partnership (TTIP): A Civil Society Response to the Big Pharma Wish List

Excerpt from a joint position paper by the Commons Network, Medicines in Europe Forum, International Society of Drugs Bulletins, Health Action International Europe, UAEM Europe, and Salud Por Derecho. The full paper is posted here, under a Creative Commons license (CC-BY). …The industry wish list includes several proposals to achieve strengthened intellectual property rules: Author […]

Berne’s Vanishing Ban on Formalities

Author: Christopher Jon Sprigman Abstract: Not too long ago, conventional wisdom in the copyright field condemned copyright formalities as unnecessary and pernicious, and celebrated their removal from American law. Recently, however, an increasingly prominent strand of copyright scholarship has begun to rue the death of mandatory formalities and to note the many possible benefits of […]

Ukraine Given a Pass on Special 301 Threats

The United States Trade Representative (USTR) recently announced that it would not seek sanctions against Ukraine following its designation as a Priority Foreign Country in the Special 301 process last year. The notice states that the USTR sticks by its finding that “certain intellectual property rights (IPR) acts, policies, and practices of Ukraine are unreasonable […]

Indian Health Ministry urged to begin providing Hep C treatment now, oppose patent on new Hepatits C drug and demand affordable access

[Médecins Sans Frontières, Link] With oral drugs promising to simplify and improve hepatitis C (HCV) treatment, the Indian Health Ministry should start rolling out treatment now for the millions of people waiting, said the Delhi Network of Positive People (DNP+) at a protest held today outside the premises of the Ministry of Health & Family […]